Investing

3M Raises 2026 Earnings Outlook but Settlement Payments Loom Over 2027 and 2028

By Bear Creek Staff, . Bear Creek Capital Network.

3M Raises 2026 Earnings Outlook but Settlement Payments Loom Over 2027 and 2028

3M raised its full-year 2026 adjusted earnings-per-share outlook to a range of $9.10 to $9.15, up from a prior range of $8.80 to $8.95, while holding its organic sales growth forecast above 3.5%, The Motley Fool reported following the company's third-quarter results.

What the numbers show

The growth cadence tells the cleaner story. Organic year-over-year sales growth ran at 1.2% in the first quarter of 2026, 2.3% in the second, 3.3% in the third, and management expects something above 4% in the fourth. That sequential acceleration has come despite headwinds: weakness in automotive and consumer electronics, softness in home improvement, and an inflation drag from oil prices that management now puts at $185 million for the full year, above an earlier estimate of $150 million to $175 million.

Management also confirmed a target of $4.8 billion in adjusted free cash flow (cash remaining after operating costs and capital spending) for the year. At the current share price, the report puts the price-to-adjusted-free-cash-flow multiple at 18.4.

Where the risk sits

The adjusted free cash flow figure excludes legal settlement obligations, and those are the numbers that matter most for the next two years. The company owes $2.6 billion in 2027 and $1.6 billion in 2028 tied to PFAS, or "forever chemicals," contamination remediation for US public water suppliers. A separate set of payments relates to combat arms earplugs litigation. After 2028, the remaining PFAS obligations total $3.3 billion spread across 2029 through 2036, a much lighter annual burden.

For investors focused on the adjusted free cash flow run rate, those settlement years are a known drag rather than an unknown risk. For anyone expecting the valuation case to close quickly, they are the reason it may not.

What management is building

Chief Executive Officer Bill Brown has made new product introductions a central part of the operational story. The company logged 87 new product introductions in the third quarter and is targeting 350 for the full year. Brown was quoted in the report saying "our ability to drive price right now is partly from the new products," a point that matters in an inflationary environment where volume growth alone is harder to sustain.

The report also noted that industrial supplier Fastenal's results had already flagged improvement in heavy equipment, data centers, aerospace, and machine products in 2026, themes that showed up in 3M's own quarter.

What to watch

The investment case here is straightforward to describe and slow to resolve. Operational momentum is building, the valuation on adjusted free cash flow looks reasonable, and the new product pipeline is a genuine source of pricing power. The complication is that 2027 and 2028 cash outflows from settlements will suppress reported free cash flow well below the adjusted figure, which could keep the stock range-bound even if the underlying business keeps improving.

The practical question for anyone watching 3M is whether the settlement schedule is already priced in or whether the market will reprice it again each time a payment approaches. That answer will likely come from how the stock behaves as the 2027 payment date draws closer, not from the operating results alone.

Source: https://www.fool.com/investing/2026/10/26/prediction-3m-will-reward-patient-investors/?source=iedfolrf0000001

Bear Creek Capital Network publishes content for informational and educational purposes only. Nothing in this article constitutes financial, investment, tax or legal advice, or a recommendation to buy or sell any security. Consider your own circumstances and consult a qualified professional before making financial decisions.

More from Bear Creek Capital Network